Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer
Efthymia-Iliana Matthaiou,1,2 Jaleh Barar,1,3 Raphael Sandaltzopoulos,2 Chunsheng Li,1 George Coukos,1,4 Yadollah Omidi1,3 1Ovarian Cancer Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; 2Department of Molecular Biology and Genetics, Democritus Unive...
Guardado en:
Autores principales: | Matthaiou EI, Barar J, Sandaltzopoulos R, Li C, Coukos G, Omidi Y |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d7d0745d409d41df9f5d87e79f6f85f1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Successful in vivo hyperthermal therapy toward breast cancer by Chinese medicine shikonin-loaded thermosensitive micelle
por: Su Y, et al.
Publicado: (2017) -
IR780-loaded folate-targeted nanoparticles for near-infrared fluorescence image-guided surgery and photothermal therapy in ovarian cancer
por: Song J, et al.
Publicado: (2019) -
Silencing of MEF2D by siRNA Loaded Selenium Nanoparticles for Ovarian Cancer Therapy
por: Wang C, et al.
Publicado: (2020) -
Paclitaxel-Loaded Macrophage Membrane Camouflaged Albumin Nanoparticles for Targeted Cancer Therapy
por: Cao X, et al.
Publicado: (2020) -
Ovarian cancer: emerging molecular-targeted therapies
por: Sourbier C
Publicado: (2012)